Butilbrometo de Escopolamina is an anticholinergic medicine. Butilbrometo de Escopolamina has many effects in the body including decreasing the secretion of fluids, slowing the stomach and intestines, and dilation of the pupils.
Butilbrometo de Escopolamina is used to relieve nausea, vomiting, and dizziness associated with motion sickness and recovery from anesthesia and surgery. Butilbrometo de Escopolamina may also be used in the treatment of parkinsonism, spastic muscle states, irritable bowel syndrome, diverticulitis, and other conditions.
Butilbrometo de Escopolamina may also be used for purposes other than those listed in this medication guide.
Butilbrometo de Escopolamina indications
An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.
sponsored
Butilbrometo de Escopolamina transdermal system is indicated in adults for the prevention of:
•
nausea and vomiting associated with motion sickness.
•
post-operative nausea and vomiting (PONV) associated with recovery from anesthesia and/or opiate analgesia and surgery.
How should I use Butilbrometo de Escopolamina?
Use Butilbrometo de Escopolamina drops as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Butilbrometo de Escopolamina drops is only for the eye. Do not get it in your nose or mouth.
To use Butilbrometo de Escopolamina drops in the eye, first, wash your hands. Tilt your head back. Using your index finger, pull the lower eyelid away from the eye to form a pouch. Drop the medicine into the pouch and gently close your eyes. Immediately use your finger to apply pressure to the inside corner of the eyelid for 1 to 2 minutes. Do not blink. Remove excess medicine around your eye with a clean, dry tissue, being careful not to touch your eye. Wash your hands to remove any medicine that may be on them.
To prevent germs from contaminating your medicine, do not touch the applicator tip to any surface, including the eye. Keep the container tightly closed.
If you miss a dose of Butilbrometo de Escopolamina drops, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.
Ask your health care provider any questions you may have about how to use Butilbrometo de Escopolamina drops.
Uses of Butilbrometo de Escopolamina in details
There are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.
sponsored
This medication is used to widen the pupils for eye examination or eye surgery. It is also used to decrease pain and swelling from an inflammation of the eye (iridocyclitis). It belongs to a class of drugs known as anticholinergics. Butilbrometo de Escopolamina works by blocking the effects of a certain natural chemical (acetylcholine) on certain eye muscles, causing relaxation of these muscles. This effect causes the pupil to widen and the lens to temporarily lose the ability to focus. Butilbrometo de Escopolamina decreases pain in eye inflammation by relaxing the eye muscles.
How to use Butilbrometo de Escopolamina ophthalmic
If you are using this medication for eye inflammation, apply it to the eye up to 3 or 4 times a day or as directed by your doctor. If you are using this medication to widen the pupil, it is usually applied in the eye 1 hour before the procedure/exam or as directed by your doctor. This medication is for use in the eye only. Do not take by mouth or inject.
To apply eye drops, wash your hands first. To avoid contamination, do not touch the dropper tip or let it touch your eye or any other surface.
If you are wearing contact lenses, remove them before using these eye drops. Ask your doctor when you can start wearing your contact lenses again.
Tilt your head back, look upward, and pull down the lower eyelid to make a pouch. Hold the dropper directly over your eye and place 1 drop into the pouch as directed by your doctor. Look downward and gently close your eyes for 1 to 2 minutes. Place one finger at the corner of your eye (near the nose) and apply gentle pressure for 2 to 3 minutes. This will prevent the medication from draining away from the eye and will also help reduce side effects. Try not to blink and do not rub your eye. Repeat these steps if your dose is for more than 1 drop or for your other eye if so directed. Wash your hands after applying eye drops.
If you are applying eye drops into a child's eyes, wash your hands and the child's hands afterwards. Be careful not to get any drops in the child's mouth.
Do not rinse the dropper. Replace the dropper cap after each use.
If you are using another kind of eye medication (e.g., drops or ointments), ask your doctor if you should continue to use them with this medication and when you should start them again. Use eye drops before eye ointments to allow the drops to enter the eye.
If you have been directed to use this medicine more than 1 time (e.g., for eye inflammation), use it regularly in order to get the most benefit from it. To help you remember, use it at the same time(s) each day. Continue using it for the full time prescribed.
This medication starts to work in minutes, and its effect usually lasts for several days or sometimes longer. Tell your doctor if you continue to have blurred vision, sensitivity to light, or widened pupils 1 week after your exam. If you are treating inflammation, tell your doctor if your condition does not improve or if it worsens.
Butilbrometo de Escopolamina description
sponsored
An alkaloid from Solanaceae, especially Datura metel L. and Scopola carniolica. Butilbrometo de Escopolamina Hydrobromide Trihydrate and its quaternary derivatives act as antimuscarinics like atropine, but may have more central nervous system effects. Among the many uses are as an anesthetic premedication, in urinary incontinence, in motion sickness, as an antispasmodic, and as a mydriatic and cycloplegic.
Butilbrometo de Escopolamina dosage
Butilbrometo de Escopolamina Dosage
Applies to the following strength(s): 1.5 mg; 1 mg/mL; 0.4 mg/mL; 0.4 mg
The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.
Usual Adult Dose for:
Nausea/Vomiting
Motion Sickness
Parkinsonian Tremor
Usual Pediatric Dose for:
Nausea/Vomiting
Motion Sickness
Additional dosage information:
Renal Dose Adjustments
Liver Dose Adjustments
Precautions
Dialysis
Other Comments
Usual Adult Dose for Nausea/Vomiting
General antiemetic use: 0.3 to 0.65 mg administered IV, intramuscularly or subcutaneously every 6 to 8 hours as needed.
Post-operative nausea and vomiting use: apply one Butilbrometo de Escopolamina 1.5 mg transdermal disc behind the ear the evening before the scheduled surgery. The disc should remain in place for 24 hours after surgery before discarding.
If using Butilbrometo de Escopolamina transdermal on an obstetrics patient, apply the disc one hour prior to scheduled Cesarean section to limit exposure to the infant.
Usual Adult Dose for Motion Sickness
Apply one Butilbrometo de Escopolamina 1.5 mg transdermal disc behind the ear at least 4 hours prior to exposure every 3 days as needed.
Usual Adult Dose for Parkinsonian Tremor
0.4 to 0.8 mg orally every 8 hours as needed.
Usual Pediatric Dose for Nausea/Vomiting
1 to 12 years: 6 mcg/kg/dose (maximum dose: 0.3 mg/dose) administered IV, IM or subcutaneous every 6 to 8 hours as needed.
Usual Pediatric Dose for Motion Sickness
Greater than 12 years: apply one Butilbrometo de Escopolamina 1.5 mg transdermal disc behind the ear at least 4 hours prior to exposure every 3 days as needed.
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
As with other anticholinergic agents, Butilbrometo de Escopolamina is contraindicated for patients with angle-closure glaucoma, prostatic hypertrophy, and pyloric obstruction. It should not be administered to patients with impaired hepatic or renal function.
Butilbrometo de Escopolamina may cause drowsiness, confusion, and disorientation. The elderly may be particularly sensitive to these effects. All patients should be cautioned against engaging in activities which require mental alertness, such as driving or operating dangerous machinery, while using the Butilbrometo de Escopolamina transdermal patch. The concomitant use of alcohol or other agents possessing CNS depressant activity should be avoided if possible.
Butilbrometo de Escopolamina may aggravate seizures (although this association has been disputed) and psychoses and should be used cautiously in patients with a history of such disorders.
Use with caution in patients with cardiac disease and in the elderly.
The safety and efficacy of Butilbrometo de Escopolamina in children have not been determined.
Dialysis
Data not available
Other Comments
Butilbrometo de Escopolamina transdermal patches contain residual drug when removed after being applied for 72 hours. Patients should wash their hands well with soap and water to prevent accidental transfer of Butilbrometo de Escopolamina to eyes or mucosal surfaces. Once removed, the patch should be folded against itself such that the adhesive side containing residual drug is not accessible.
Only one transdermal patch should be on the patient at any given time during therapy; remove the used disc prior to placing a fresh disc on the skin.
More about Butilbrometo de Escopolamina
Side Effects
During Pregnancy or Breastfeeding
Dosage Information
Drug Interactions
Support Group
92 Reviews - Add your own review/rating
Consumer resources
Butilbrometo de Escopolamina
Butilbrometo de Escopolamina patch
Butilbrometo de Escopolamina transdermal
Butilbrometo de Escopolamina Transdermal (Advanced Reading)
Other brands: Transderm-Scop, Butilbrometo de Escopolamina, Maldemar
The absorption of oral medications may be decreased during the concurrent use of Butilbrometo de Escopolamina because of decreased gastric motility and delayed gastric emptying.
Butilbrometo de Escopolamina Hydrobromide Trihydrate should be used with care in patients taking other drugs that are capable of causing CNS effects such as sedatives, tranquilizers, or alcohol. Special attention should be paid to potential interactions with drugs having anticholinergic properties; e.g., other belladonna alkaloids, antihistamines (including meclizine), tricyclic antidepressants, and muscle relaxants.
Laboratory Test Interactions
Butilbrometo de Escopolamina Hydrobromide Trihydrate will interfere with the gastric secretion test.
Applies to Butilbrometo de Escopolamina: transdermal patch extended release
As well as its needed effects, Butilbrometo de Escopolamina (the active ingredient contained in Butilbrometo de Escopolamina) may cause unwanted side effects that require medical attention.
Major Side Effects
If any of the following side effects occur while taking Butilbrometo de Escopolamina, check with your doctor immediately:
Incidence not known:
Blurred vision
chest pain or discomfort
difficulty with urinating
dilation of the pupils
dizziness, faintness, or lightheadedness when getting up from a lying or sitting position suddenly
eye pain
flushing or redness of the skin
mood or mental changes
muscle weakness
nausea or vomiting
rash
redness of the white part of the eyes
restlessness
seeing, hearing, or feeling things that are not there
shortness of breath
slow or irregular heartbeat
sweating
unusual tiredness
unusually warm skin
If any of the following symptoms of overdose occur while taking Butilbrometo de Escopolamina, get emergency help immediately:
Symptoms of overdose:
Anxiety
blurred or loss of vision
change in consciousness
decrease in frequency of urination
decrease in urine volume
difficulty in passing urine (dribbling)
disturbed color perception
double vision
dry mouth
dry, flushed skin
fast, pounding, or irregular heartbeat or pulse
halos around lights
headache
hyperventilation
irritability
loss of consciousness
nervousness
night blindness
overbright appearance of lights
painful urination
pounding in the ears
seizures
shaking
sleepiness
trouble with sleeping
tunnel vision
unusual drowsiness, dullness, tiredness, weakness, or feeling of sluggishness
Hypersensitivity to hyoscine-N-butylbromide, belladonna alkaloids or derivatives, or any other ingredients of Butilbrometo de Escopolamina.
Tablet: Patients with glaucoma, toxic megacolon (a very enlarged bowel), myasthenia gravis (a rare muscle wasting disease), obstructive prostatic hyperthropy (enlarged and blocked prostate), porphyria (hereditary blood disorder).
Patients who are pregnant, likely to become pregnant or breastfeeding, and children <6 years should not take hyoscine-N-butylbromide.
Injection: Patients with porphyria, untreated angle-closure glaucoma, prostatic enlargement, myasthenia gravis, and severe ulcerative colitis, or toxic megacolon, tachycardia; acute hemorrhage whose cardiovascular status is unstable; stomach or bowel obstruction, or in conditions where there is reduced bowel activity (eg, pyloroduodenal stenosis, achalasia), paralytic ileus or intestinal atony.
Butilbrometo de Escopolamina injection should not be given IM in patients being treated with anticoagulant therapy. Subcutaneous or IV routes may be used in these patients instead.
Active ingredient matches for Butilbrometo de Escopolamina:
DailyMed. "SCOPOLAMINE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
The results of a survey conducted on ndrugs.com for Butilbrometo de Escopolamina are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Butilbrometo de Escopolamina. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.
User reports
Consumer reported useful
No survey data has been collected yet
Consumer reported price estimates
No survey data has been collected yet
Consumer reported time for results
No survey data has been collected yet
Consumer reported age
No survey data has been collected yet
Consumer reviews
There are no reviews yet. Be the first to write one!
